Your healthiest, most confident self is closer than you think, and were here to support you every step of the way.
: 5 ( , , -4, -7 -1) , , ,
Adverse events such as diarrhea, constipation, nausea, and vomiting associated with the GLP-1 RAs overlap with those seen with cancer treatments, so the patient who is undergoing treatment with an emetogenic regimen for cancer will likely experience additional weight loss, which can lead to nutritional deficiencies, loss of lean muscle mass, and loss of bone mass
The shedding often becomes noticeable two to four months after starting treatment or after significant weight loss, which is a key distinguishing feature
But your average doctor has likely never heard of it, and the medical establishment has zero incentive to educate you about peptide therapies that cant be patented or monopolized
It has the potential to improve adherence and make diabetes management and weight loss easier for many